Table 1. Peripheral T-cell lymphoma Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Peripheral T-cell lymphoma Therapy Market Restraints

Table 3. Peripheral T-cell lymphoma Therapy Market Trends

Table 4. Peripheral T-cell lymphoma Therapy Industry Policy

Table 5. Global Peripheral T-cell lymphoma Therapy Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Company (2018-2023)

Table 7. Global Peripheral T-cell lymphoma Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Peripheral T-cell lymphoma Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global Peripheral T-cell lymphoma Therapy Manufacturers Product Type

Table 10. China Peripheral T-cell lymphoma Therapy Revenue by Company (2018-2023) & (US$ million)

Table 11. China Peripheral T-cell lymphoma Therapy Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Peripheral T-cell lymphoma Therapy Upstream (Raw Materials)

Table 13. Global Peripheral T-cell lymphoma Therapy Typical Customers

Table 14. Peripheral T-cell lymphoma Therapy Typical Distributors

Table 15. By Type, Global Peripheral T-cell lymphoma Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Peripheral T-cell lymphoma Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Peripheral T-cell lymphoma Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Peripheral T-cell lymphoma Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2029

Table 22. Antengene Company Information, Head Office, Market Area and Industry Position

Table 23. Antengene Company Profile and Main Business

Table 24. Antengene Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 25. Antengene Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 26. Antengene Recent Developments

Table 27. Genor BioPharma Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 28. Genor BioPharma Co., Ltd. Company Profile and Main Business

Table 29. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 30. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 31. Genor BioPharma Co., Ltd. Recent Developments

Table 32. Hospira (Pfizer Inc.) Company Information, Head Office, Market Area and Industry Position

Table 33. Hospira (Pfizer Inc.) Company Profile and Main Business

Table 34. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 35. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 36. Hospira (Pfizer Inc.) Recent Developments

Table 37. Dizal Pharma Company Information, Head Office, Market Area and Industry Position

Table 38. Dizal Pharma Company Profile and Main Business

Table 39. Dizal Pharma Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 40. Dizal Pharma Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 41. Dizal Pharma Recent Developments

Table 42. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

Table 43. Bristol-Myers Squibb Company Company Profile and Main Business

Table 44. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 45. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 46. Bristol-Myers Squibb Company Recent Developments

Table 47. Sigma-Tau Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

Table 48. Sigma-Tau Pharmaceuticals, Inc. Company Profile and Main Business

Table 49. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 50. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 51. Sigma-Tau Pharmaceuticals, Inc. Recent Developments

Table 52. Pacira Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

Table 53. Pacira Pharmaceuticals, Inc. Company Profile and Main Business

Table 54. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 55. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 56. Pacira Pharmaceuticals, Inc. Recent Developments

Table 57. Spectrum Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

Table 58. Spectrum Pharmaceuticals, Inc. Company Profile and Main Business

Table 59. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 60. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 61. Spectrum Pharmaceuticals, Inc. Recent Developments

Table 62. Celgene Corporation Company Information, Head Office, Market Area and Industry Position

Table 63. Celgene Corporation Company Profile and Main Business

Table 64. Celgene Corporation Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 65. Celgene Corporation Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 66. Celgene Corporation Recent Developments

Table 67. Eisai Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 68. Eisai Co., Ltd. Company Profile and Main Business

Table 69. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 70. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 71. Eisai Co., Ltd. Recent Developments

Table 72. Leadiant Biosciences Company Information, Head Office, Market Area and Industry Position

Table 73. Leadiant Biosciences Company Profile and Main Business

Table 74. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 75. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 76. Leadiant Biosciences Recent Developments

Table 77. Merck Company Information, Head Office, Market Area and Industry Position

Table 78. Merck Company Profile and Main Business

Table 79. Merck Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 80. Merck Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 81. Merck Recent Developments

Table 82. Genmab AS Company Information, Head Office, Market Area and Industry Position

Table 83. Genmab AS Company Profile and Main Business

Table 84. Genmab AS Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 85. Genmab AS Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 86. Genmab AS Recent Developments

Table 87. HUYABIO International Company Information, Head Office, Market Area and Industry Position

Table 88. HUYABIO International Company Profile and Main Business

Table 89. HUYABIO International Peripheral T-cell lymphoma Therapy Models, Specifications and Application

Table 90. HUYABIO International Peripheral T-cell lymphoma Therapy Revenue and Gross Margin, 2018-2023

Table 91. HUYABIO International Recent Developments

List of Figure

Figure 1. Peripheral T-cell lymphoma Therapy Picture

Figure 2. Global Peripheral T-cell lymphoma Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Peripheral T-cell lymphoma Therapy Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Peripheral T-cell lymphoma Therapy Market Share of Global

Figure 5. Global Peripheral T-cell lymphoma Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Peripheral T-cell lymphoma Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Peripheral T-cell lymphoma Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Peripheral T-cell lymphoma Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Peripheral T-cell lymphoma Therapy Industry Chain

Figure 10. Chidamide

Figure 11. Selinexor

Figure 12. Other

Figure 13. By Type, Global Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2029

Figure 15. Hospitals

Figure 16. Clinics

Figure 17. By Application, Global Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, US$ Million

Figure 18. By Application, Global Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2029

Figure 19. By Region, Global Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2029

Figure 20. North America Peripheral T-cell lymphoma Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 21. By Country, North America Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2023

Figure 22. Europe Peripheral T-cell lymphoma Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, Europe Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2023

Figure 24. Asia Pacific Peripheral T-cell lymphoma Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country/Region, Asia Pacific Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2023

Figure 26. South America Peripheral T-cell lymphoma Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, South America Peripheral T-cell lymphoma Therapy Revenue Market Share, 2018-2023

Figure 28. Middle East & Africa Peripheral T-cell lymphoma Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. U.S. Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 30. By Company, U.S. Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 31. By Type, U.S. Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 33. Europe Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, Europe Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 35. By Type, Europe Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 36. By Application, Europe Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 37. China Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, China Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 39. By Type, China Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 40. By Application, China Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 41. Japan Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, Japan Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 43. By Type, Japan Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 44. By Application, Japan Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 45. South Korea Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, South Korea Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 47. By Type, South Korea Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 48. By Application, South Korea Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 49. Southeast Asia Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, Southeast Asia Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 51. By Type, Southeast Asia Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 52. By Application, Southeast Asia Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 53. India Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, India Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 55. By Type, India Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 56. By Application, India Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 57. Middle East & Asia Peripheral T-cell lymphoma Therapy Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, Middle East & Asia Peripheral T-cell lymphoma Therapy Market Share, 2018-2023

Figure 59. By Type, Middle East & Asia Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 60. By Application, Middle East & Asia Peripheral T-cell lymphoma Therapy Revenue Market Share, 2022 VS 2029

Figure 61. Research Methodology

Figure 62. Breakdown of Primary Interviews

Figure 63. Bottom-up Approaches

Figure 64. Top-down Approaches